Tag: AusBioTech

post-image

BioTech is hardest hit by R&D changes

The Life Sciences industry in Australia will be hit disproportionately hard by proposed changes to the R&D Tax Incentive, putting smaller companies at risk and threatening the sector’s ability...

R&D changes to ‘devastate’ biotech

Posted on   |  by James Riley
Potential changes to the R&D tax incentive would “devastate” the booming biotechnology industry in Australia, a new report has found. The Biotechnology Industry Position Survey 2017 found that the...